Microdosing GLP-1 for autoimmune conditions is an emerging approach that some providers use to balance weight management with autoimmune disease management
Segn las guas de la American Diabetes Association (ADA), los agonistas del receptor GLP-1 con beneficio cardiovascular demostrado se recomiendan para pacientes con diabetes tipo 2 que tienen enfermedad cardiovascular aterosclertica o alto riesgo cardiovascular, independientemente del uso de metformina
Dual Treatments Dual GLP- 1/GIP Receptor co-agonist Tirzepatide Tirzepatide is the first dual GLP- 1/GIP receptor co-agonist [98]
Ask if Zepbound (or Mounjaro) is covered and what your copay will be
The Weight Loss and GERD Connection The relationship between obesity and GERD creates an interesting therapeutic arc for patients on this combination
A tan can feel like a shortcut to looking rested, sharper, and vacation ready, even if your sleep, diet, and stress were a mess all week